Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$574K Sell
2,018
-4,110
-67% -$1.2M 0.23% 57
2023
Q4
$1.76M Buy
6,128
+492
+9% +$134K 0.74% 17
2023
Q3
$1.51M Sell
5,636
-98
-2% -$24.5K 0.68% 18
2023
Q2
$1.27M Buy
5,734
+777
+16% +$180K 0.55% 24
2023
Q1
$1.11M Buy
4,957
+2,190
+79% +$538K 0.51% 34
2022
Q4
$727K Buy
+2,767
New +$742K 0.42% 34

Other funds holding AMGN

RIA Advisory Group's AMGN Position: Q1 2024 in Review

RIA Advisory Group reduced its Amgen (AMGN) stake by 67% in Q1 2024, selling an estimated $1.2M and leaving 2,018 shares worth $574K. The position accounts for 0.23% of the portfolio, ranked #57.

RIA Advisory Group first reported a position in AMGN in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.76M in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • RIA Advisory Group held 2,018 shares of Amgen worth $574K as of Q1 2024.
  • RIA Advisory Group sold 4,110 Amgen shares in Q1 2024, an estimated $1.2M.
  • Amgen made up 0.23% of RIA Advisory Group's portfolio in Q1 2024, its #57 holding.
  • RIA Advisory Group first reported a position in Amgen in Q4 2022 and has held it in 6 quarters since.
  • RIA Advisory Group's Amgen position peaked at $1.76M in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on RIA Advisory Group's 13F filing for Q1 2024, filed 3 May 2024.